Announcement on Implementing Cancellation of Repurchased Shares and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Implementing Cancellation of Repurchased Shares and Share Changes
Filed with SSE ·
On 6ix: 6ix.com/news/announcement-on-implementing-cancellation-of-repurchased-shares-and-share-changes-16
6ix hasn’t read this filing yet.
HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix
Earlier from HeiLongJiang ZBD Pharmaceutical
- Indicative Announcement on Premature Delisting of the Non-public Offering of Exchangeable Corporate Bonds by the Controlling Shareholder (Phase II) and the Proposed Release of the Remaining Pledged Shares
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Change in Equity of Controlling Shareholder
- Indicative Announcement on Completion of the Delisting of the Non-public Offering of Exchangeable Corporate Bonds by the Controlling Shareholder (Phase I) and the Proposed Release of the Remaining Pledged Shares
- Indicative Announcement on Change in Equity of Controlling Shareholder Reaching 1% Scale
Later from HeiLongJiang ZBD Pharmaceutical
- Announcement on Postponement of Disclosure of 2025 Annual Report
- Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
- Announcement on Completion of the Pledge Release on the Remaining Pledged Shares of the Non-publicly Issued Exchangeable Corporate Bonds by the Controlling Shareholder
- Announcement on Proposed Inclusion of Some Drugs in the Centralized Volume Procurement of National Chinese Patent Medicine Procurement Alliance
- Announcement on Progress in Providing Guarantee for Wholly-owned Subsidiaries
Follow HeiLongJiang ZBD Pharmaceutical into a list and get an email when it puts out news.
Follow HeiLongJiang ZBD Pharmaceutical